Table 1. Clinical and laboratory information study participants with and without HBV and HCV, with different degrees of disease.

Variables	HBV chronic hepatitis	HCV chronic hepatitis	Non-viral chronic hepatitis	Normal control
Study subjects (n)	6	28	9	8
Gender (F/M)	4/2	16/12	5/4	5/3
ALT (UI/L) Mean ± SD	35.8 ± 60.8	89 ± 97.1	97 ± 76.21	27 ± 8.11
Median	30.5	56	96	27
GGT (UI/L) Mean ± SD	30 ± 14.7	78 ± 98.8	170 ± 141.77	29 ± 10.74
Median	20.5	55	155	29
Fibrosis Stage a
F0 (%)	1 (16.7)	2 (7.1)	1 (16.7)	8 (100.0)
F1 (%)	4 (66.6)	13 (46.5)	2 (33.3)	-
F2 (%)	-	7 (25.0)	-	-
F3 (%)	-	3 (10.7)	1 (16.7)	-
F4 (%)	1 (16.7)	3(10.7)	2 (33.3)	-
Inflammation Stage b
A0 (%)	1 (16.7)	4 (14.3)	1 (16.7)	8 (100.0)
A1 (%)	4 (66.6)	13 (46.4)	4 (66.6)	-
A2 (%)	1 (16.7)	11 (39.3)	1 (16.7)	-

ALT: alanine aminotransferase; GGT: gamma-glutamyl transferase;

^aFibrosis Stages—F0: no fibrosis; F1: portal without septa; F2: portal with some septa; F3: many septa without cirrhosis; F4: cirrhosis;

^bInflammation Stages—A0: absent; A1: mild; A2: moderate.